Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
The economic burden of overweight and obesity in Europe
24 September 2026
Effective obesity strategies require action across government and society, and a broader approach to evaluating their costs and benefits.
Around the World in HTAs: Zimbabwe – Seizing a window of opportunity
24 September 2026
Zimbabwe has an opportunity to embed health technology assessment (HTA) into its health system as it works towards Universal Health Coverage (UHC) by 2030. Currently, the country provides access to just 55% of the benchmarked essential health services.
Compared to what? How the choice of comparator affects new medicines
14 September 2026
Comparator choice shapes health technology assessment: it sets the benchmark a new medicine is assessed against, driving both patient access and where firms invest in R&D. We consider five theoretical comparator examples and, for each, assess the implications of comparator selection on access, launch decisions and innovation incentives for new medicines.
What the first EU JCA reveals about assessing precision oncology
28 July 2026
We explore how the first JCA provides insights into the longstanding methodological challenge of evidence generation and comparative assessment for precision medicine.
Around the world in HTAs: Abu Dhabi – Advancing HTA and value-based healthcare in the UAE
1 July 2026
Abu Dhabi is taking important steps to strengthen the use of HTA in healthcare decision-making, with the publication of its HTA guidelines in 2025 marking an important milestone.
The impact of inflation on incremental costs in HTA
4 June 2026
Inflation reshapes the economic landscape in which new treatments are evaluated. Yet cost-effectiveness thresholds tend to remain fixed over time. This report examines how inflation in…
One Europe, one assessment? Unpacking the European Joint Clinical Assessment
28 May 2026
As the first EU Joint Clinical Assessment reports approach, national HTA systems across Europe are already adapting to a new era of coordinated clinical evaluation.
The value of fast diagnostics in time-critical infections
20 April 2026
Advancing earlier intervention in time‑critical infections Sepsis continues to impose a substantial global burden, with millions of cases and high mortality each year. Patients with bloodstream…
Around the World in HTAs: Japan – An algorithmic approach to containing costs
14 April 2026
Japan’s health technology assessment (HTA) system uses algorithmic drug pricing and cost-effectiveness analysis to manage rising healthcare costs while maintaining universal access and innovation.